DrugResearcher RSS

New China:US preclinical partnership formed

Kirsty Barnes — Wed, 02 Jan 2008 11:00:00 +0100

US-based MPI Research and China's Shanghai Medicilon have formed a joint venture in preclinical services, as they position themselves to cash in on what is a budding market sector in China.

A drug cocktail to bust brain tumours

Mike Nagle — Wed, 02 Jan 2008 11:00:00 +0100

A team of US researchers have uncovered a cocktail of three drugs that could be effective at treating every patient with a particular type of brain cancer that typically has a dismal prognosis.

IDM Pharma will cut jobs after Sanofi scraps melanoma collaboration

staff reporter — Wed, 02 Jan 2008 11:00:00 +0100

Sanofi-Aventis has decided to pull out of its skin cancer collaboration with IDM Pharma, leaving the Californian biopharma firm considering job cuts as a way to lower costs.

More pharmas implicated in Iraq bribery probe

Anna Lewcock — Wed, 02 Jan 2008 11:00:00 +0100

While GSK, AstraZeneca and Eli Lilly have hit the headlines in the UK Serious Fraud Office's (SFO) investigation into illegal bribes paid to Saddam Hussein's Iraqi regime, many more pharma firms are on the organisation's hit list.

New drug target leaves lung cancer cells alone, lonely and dying

Mike Nagle — Wed, 02 Jan 2008 11:00:00 +0100

It seems even tumour cells can get lonely; scientists have discovered that by cutting off a key gene, lung cancer tumour cells are left 'homeless' and they can't survive on their own.

Small molecules still leading the way into the clinic

Mike Nagle — Thu, 20 Dec 2007 11:00:00 +0100

DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007.

Biochips help reduce the need for animal testing

Dr Matt Wilkinson — Thu, 20 Dec 2007 11:00:00 +0100

US researchers have developed a new biochip technology that could dramatically reduce the need for animal testing during drug development safety studies.

Mapping the 'human embryome' in BioTime

Dr Matt Wilkinson — Wed, 19 Dec 2007 11:00:00 +0100

BioTimes' subsidiary, Embryome Sciences, is planning to build a relational database that will help identify the hundreds of cell types that can be made from human and mouse embryonic stem cells.

New drug on the blocks for athletes

Mike Nagle — Wed, 19 Dec 2007 11:00:00 +0100

Scientists have discovered a potential new drug target that will prick up the ears of sportsmen and athletes alike. Not that this is an performance-enhancing drug; instead, it could help athletes recover from injury more quickly.

Pfizer buys CovX to bulk biologics pipeline

Mike Nagle — Wed, 19 Dec 2007 11:00:00 +0100

Pfizer, the world's largest pharma firm, has reached into its pockets to buy CovX, a privately-held US biotech that specialises in combining the strengths of peptides and antibodies into new drugs.